Procédés de traitement de cancers hématologiques utilisant des inhibiteurs PNP tels que du forodesine en combinaison avec des agents d'alkylation ou des agents anti-CD20
- 专利权人:
- Biocryst Pharmaceuticals; Inc.
- 发明人:
- 申请号：
- EP12196293.0
- 公开号：
- EP2581083A1
- 申请日:
- 2008.12.10
- 申请国别(地区):
- EP
- 年份:
- 2013
- 代理人:
- 摘要：
- The present application relates to treatment of hematologic cancers, which treatments can include, e.g., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- METHODS OF TREATING HEMATOLOGIC CANCERS USING PNP INHIBITORS SUCH AS FORODESINE IN COMBINATION WITH ALKYLATING AGENTS OR ANTI-CD20 AGENTS
- METHOD OF TREATING HEMATOLOGIC CANCER USING PNP INHIBITORS SUCH AS FORODESINE IN COMBINATION WITH ALKYLATING AGENTS OR ANTI-CD20 AGENTS
- Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents
- Methods of treating hematologic cancers using PNP inhibitors such as forodesine in combination with alkylating agents or anti-CD20 agents
- -20 METHODS OF TREATING HEMATOLOGIC CANCERS USING PNP INHIBITORS SUCH AS FORODESINE IN COMBINATION WITH ALKYLATING AGENTS OR ANTI-CD20 AGENTS
